Literature DB >> 20347540

Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal?

Kristina I Ringe1, Daniela B Husarik, Rajan T Gupta, Daniel T Boll, Elmar M Merkle.   

Abstract

OBJECTIVE: The purpose of this study was to determine transit times for excretion of Gd-EOB-DTPA into different segments of the hepatobiliary system in patients with normal liver function.
METHODS: This retrospective study was IRB approved with a waiver of consent granted. 61 patients (39 female, 22 male, mean age 52.5 years) with normal liver and renal function who underwent contrast enhanced hepatic MRI after injection of 10 mL Gd-EOB-DTPA at 1.5T and 3T were included. Two readers evaluated all delayed images (3-20 min post contrast) for the presence of contrast agent in the intrahepatic bile ducts (IBD), the common bile duct (CBD), the gallbladder and the duodenum. A two-tailed, unpaired Student's t-test with p<0.05 deemed significant was used to determine whether transit times were affected by patient gender, age or body mass index.
RESULTS: 20 min after contrast initiation, Gd-EOB-DTPA could be detected in the IBD and the CBD in all patients (100%); gallbladder reflux was visible in 53 (86.9%), duodenal excretion in 40 patients (65.5%), respectively. Mean transit times for contrast appearance in the various segments were as follows: IBD 12 min 13s; CBD 12 min 27 s; gallbladder 13 min 32s. Transit times were not significantly affected by patient gender, age or BMI.
CONCLUSION: Within 20 min post contrast initiation, Gd-EOB-DTPA can be expected in the IBD and the CBD in patients with normal liver function. However, functional information about the sphincter Oddi complex can be ascertained only in about two thirds of these patients within this timeframe.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347540     DOI: 10.1016/j.ejrad.2010.03.008

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

1.  Biliary reflux detection in anomalous union of the pancreatico-biliary duct patients.

Authors:  Suk Keu Yeom; Seung Wha Lee; Sang Hoon Cha; Hwan Hoon Chung; Bo Kyung Je; Baek Hyun Kim; Jong Jin Hyun
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.

Authors:  Rama S Ayyala; Sudha A Anupindi; Michael S Gee; Andrew T Trout; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-07-26

Review 3.  Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.

Authors:  YoonSeok Choi; Jimi Huh; Dong-Cheol Woo; Kyung Won Kim
Journal:  Br J Radiol       Date:  2015-12-23       Impact factor: 3.039

4.  Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Authors:  Mustafa R Bashir; Steven R Breault; Ryan Braun; Richard K Do; Rendon C Nelson; Scott B Reeder
Journal:  Acad Radiol       Date:  2014-04-06       Impact factor: 3.173

5.  Functional hepatobiliary MR imaging in children.

Authors:  Anobel Tamrazi; Shreyas S Vasanawala
Journal:  Pediatr Radiol       Date:  2011-05-07

Review 6.  What's new in the hot gallbladder: the evolving radiologic diagnosis and management of acute cholecystitis.

Authors:  James P Nugent; Jessica Li; Emily Pang; Alison Harris
Journal:  Abdom Radiol (NY)       Date:  2022-03-01

7.  Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis.

Authors:  Alex Frydrychowicz; Andrzej R Jedynak; Frederick Kelcz; Scott K Nagle; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

8.  Accumulation of Bile in the Gallbladder: Evaluation by means of Serial Dynamic Contrast-Enhanced Magnetic Resonance Cholangiography with Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid.

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Kazuya Yasokawa; Atsushi Higaki; Akihiko Kanki; Yasufumi Noda; Akira Yamamoto
Journal:  Gastroenterol Res Pract       Date:  2014-12-17       Impact factor: 2.260

9.  Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers.

Authors:  Leonidas Georgiou; Jeffrey Penny; Glynis Nicholls; Neil Woodhouse; François-Xavier Blé; Penny L Hubbard Cristinacce; Josephine H Naish
Journal:  Invest Radiol       Date:  2017-02       Impact factor: 6.016

10.  Hepatocyte-specific contrast agent-enhanced magnetic resonance cholangiography: perioperative evaluation of the biliary tree.

Authors:  Luciana Carmen Zattar-Ramos; Regis Otaviano Franca Bezerra; Luis Tenório de Brito Siqueira; Marcos Roberto Menezes; Claudia da Costa Leite; Giovanni Guido Cerri
Journal:  Radiol Bras       Date:  2017 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.